TITLE

Photo Quiz. New-Onset Digital Clubbing

AUTHOR(S)
Wong, Eugene; Milkes, David
PUB. DATE
July 2001
SOURCE
American Family Physician;7/1/2001, Vol. 64 Issue 1, p141
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Presents a case study of a patient with hyperparathyroidism, secondary to renal osteodystrophy. Clinical presentation of the disease; Differential diagnosis; Types of hyperparathyroidism.
ACCESSION #
4800779

 

Related Articles

  • Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Jehle, Peter M.; Ostertag, Antje; Schulten, Klaus; Schulz, Walter; Jehle, Daniela R.; Stracke, Sylvia; Fiedler, Roman; Deuber, Heinz J.; Keller, Frieder; Boehm, Bernhard O.; Baylink, David J.; Mohan, Subburaman // Kidney International;Feb2000, Vol. 57 Issue 2, p423 

    Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Background. The insulin-like growth factor (IGF) system plays a key role in regulation of bone formation. In patients with renal osteodystrophy, an elevation of some IGF binding proteins (IGFBPs) has...

  • Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients. Resic, Halima; Helac-Cvijetic, Dzana; Basic, Adisa; Masnic, Fahrudin; Spanja, Indira; Avdic, Emir; Sahovic, Vahidin; Avdagic, Melka; Kukavica, Nihad // HealthMed;2010 Supplement 1, Vol. 4, p224 

    Introduction: A secondary hyperparathyroidism is frequently complication in patients undergoing hemodialysis treatment and might be an inducement of renal osteodystrophy. Aim: The aim of the study was to evaluate the effects of diabetes mellitus, age, sex, and duration of dialysis on...

  • Vertebral Brown Tumor in Childhood (Case Report). Szeverényi, Csenge; Dezső, Balázs; Deményi, Tamás; Csernátony, Zoltán // Surgical Science;Aug2011, Vol. 2 Issue 6, p344 

    One form of renal osteodystrophy secondary to chronic renal failure is the osteitis fibrosa cystica, which is the complication of secondary hyperparathyroidism. Osteitis fibrosa cystica is a histologically benign, tumor- like lesion of bones. Since early diagnosis and treatment of...

  • Linear decline in serum alkaline phosphatase activity during treatment of renal osteodystrophy. Will, Eric J.; Knapp, Martin S.; McGivern, Damien // British Medical Journal (Clinical Research Edition);1/8/1983, Vol. 286 Issue 6359, p103 

    Determines a linear decline in serum alkaline phosphatase activity during renal osteodystrophy treatment. Importance of serum alkaline phosphatase activity as an indicator of secondary hyperparathyroidism; Occurrence of hypercalcemia low phosphatase activity; Assessment on the rectilinear...

  • Hyperphosphatemia in children receiving peritoneal dialysis�an educational program. Blaszak, Richard T.; Mitsnefes, Mark M.; Ilyas, Mohammad; Salman, Scarlett D.; Belcher, Sue M.; Brady, Debbie R. // Pediatric Nephrology;Jul2005, Vol. 20 Issue 7, p967 

    Hyperphosphatemia has been associated with the development of secondary hyperparathyroidism, renal osteodystrophy, cardiovascular calcification and increased risk of death. Using a one group, pretest-posttest study design, we sought to evaluate changes in serum phosphorus, calcium, parathyroid...

  • RENALNA OSTEODISTROFIJA KOD PACIJENATA NA HEMODIJALIZI. Resic, Halima; Kucukalic-Selimovic, Elma; Kapid�ic, Adnan; Kukavica, Nihad; �ahovic, Vahidin; Ma�nic, Fahrudin // Medical Journal;jul-sep2009, Vol. 15 Issue 3, p106 

    Renal osteodistrophy is one of the most common complications of chronic renal failure and one of the risk factors of increased mortality among chronic haemodialysis patients. Aim of the study was to evaluate frequency of renal osteodistrophy in our dialysis population and to identify...

  • Acid loading during treatment with sevelamer hydrochloride: Mechanisms and clinical implications. Brezina, Barton; Qunibi, Wajeh Y.; Nolan, Charles R. // Kidney International Supplement;Sep2004, Issue 90, pS39 

    Acid loading during treatment with sevelamer hydrochloride: Mechanisms and clinical implications. Short-term and long-term studies indicate that patients treated with sevelamer hydrochloride have lower serum bicarbonate levels than patients treated with calcium-containing phosphate binders. This...

  • Safety of New Phosphate Binders for Chronic Renal Failure. Loghman-Adham, Mahmoud // Drug Safety;Dec2003, Vol. 26 Issue 15, p1093 

    Phosphate (Pi) retention is a common problem in patients with chronic kidney disease, particularly in those who have reached end-stage renal disease (ESRD). In addition to causing secondary hyperparathyroidism and renal osteodystrophy, recent evidence suggests that, in ESRD patients, high serum...

  • Development of secondary hyperparathyroidism and bone disease in diabetic rats with renal failure. Jara, Aquiles; Bover, Jordi; Felsenfeld, Arnold J. // Kidney International;Jun1995, Vol. 47 Issue 6, p1746 

    Renal osteodystrophy in diabetic patients on maintenance hemodialysis is characterized by a higher prevalence of low bone turnover and is associated with a relative deficiency of parathyroid hormone (PTH) as compared with non-diabetic hemodialysis patients. The goal of the study was to evaluate...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics